Journal article · 2012
Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).
Journal of Clinical Oncology, 30(15_suppl), e19633 · Published 20 May 2012 · DOI 10.1200/jco.2012.30.15_suppl.e19633
In brief
“Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).” is a 2012 journal article by Christine Ida Nichols and 18 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 13 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 13
- Most cited in
- 2021 (6)
- Authors
- 19
Abstract
e19633 Background: NCI PRO-CTCAE is a new patient-reported outcome measure designed to enhance adverse event (AE) reporting in clinical trials by integrating the patient experience. The PRO-CTCAE item bank includes items representing the frequency (F), severity (S) and interference (I) with usual activities of 78 symptomatic AEs. The aim of this study was to examine… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nichols, C. I., Mitchell, S. A., Lang, K., Federico, V., Castro, K. M., Rogak, L. J., Lalla, D., Clauser, S. B., Reeve, B. B., Denicoff, A. M., Chen, A. P., Piekarz, R., Atkinson, T. M., Mayer, M., Brammer, M. G., Sit, L., O’Mara, A. M., Minasian, L. M., & Basch, E. (2012). Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC). Journal of Clinical Oncology, 30(15_suppl), e19633. https://doi.org/10.1200/jco.2012.30.15_suppl.e19633
MLA 9
Nichols, Christine Ida, et al. “Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).” Journal of Clinical Oncology, vol. 30, no. 15_suppl, 2012, p. e19633. https://doi.org/10.1200/jco.2012.30.15_suppl.e19633.
Chicago
Nichols, Christine Ida, Sandra A. Mitchell, Kathy Lang, Victoria Federico, Kathleen M. Castro, Lauren J. Rogak, Deepa Lalla, et al. 2012. “Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).” Journal of Clinical Oncology 30 (15_suppl): e19633. https://doi.org/10.1200/jco.2012.30.15_suppl.e19633.
Harvard
Nichols, C. I. et al. (2012) ‘Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).’, Journal of Clinical Oncology, 30(15_suppl), p. e19633. doi:10.1200/jco.2012.30.15_suppl.e19633.
IEEE
C. I. Nichols et al., “Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).,” Journal of Clinical Oncology, vol. 30, no. 15_suppl, p. e19633, 2012, doi: 10.1200/jco.2012.30.15_suppl.e19633.
BibTeX
@article{nichols2012acceptability,
title = {{Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).}},
author = {Nichols, Christine Ida and Mitchell, Sandra A. and Lang, Kathy and Federico, Victoria and Castro, Kathleen M. and Rogak, Lauren J. and Lalla, Deepa and Clauser, Steven B. and Reeve, Bryce B. and Denicoff, Andrea M. and Chen, Alice P. and Piekarz, Richard and Atkinson, Thomas Michael and Mayer, Musa and Brammer, Melissa G. and Sit, Laura and O’Mara, Ann M. and Minasian, Lori M. and Basch, Ethan},
journal = {Journal of Clinical Oncology},
year = {2012},
volume = {30},
number = {15_suppl},
pages = {e19633},
doi = {10.1200/jco.2012.30.15_suppl.e19633},
url = {https://doi.org/10.1200/jco.2012.30.15_suppl.e19633}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 1 | |
| 2018 | 1 | |
| 2019 | 2 | |
| 2020 | 3 | |
| 2021 | 6 |
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- PRO-CTCAE
- patient-reported outcomes
- adverse event reporting
- metastatic breast cancer
- HER2-positive breast cancer
- item comprehensibility
- missing data
- insomnia
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Nichols, C. I., Mitchell, S. A., Lang, K., Federico, V., Castro, K. M., Rogak, L. J., Lalla, D., Clauser, S. B., Reeve, B. B., Denicoff, A. M., Chen, A. P., Piekarz, R., Atkinson, T. M., Mayer, M., Brammer, M. G., Sit, L., O’Mara, A. M., Minasian, L. M., & Basch, E. (2012). Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC). Journal of Clinical Oncology, 30(15_suppl), e19633. https://doi.org/10.1200/jco.2012.30.15_suppl.e19633
How many times has this paper been cited?
13 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Christine Ida Nichols, Sandra A. Mitchell, Kathy Lang, Victoria Federico, Kathleen M. Castro, Lauren J. Rogak, Deepa Lalla, Steven B. Clauser, Bryce B. Reeve, Andrea M. Denicoff, Alice P. Chen, Richard Piekarz and 7 more.
What is the DOI of this paper?
10.1200/jco.2012.30.15_suppl.e19633, permanently at https://doi.org/10.1200/jco.2012.30.15_suppl.e19633. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.